These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28320166)
1. The duration of the cortical silent period is not abnormal in Restless Legs Syndrome/Willis-Ekbom Disease. de Paiva JPQ; Magalhães SC; do Prado GF; Eckeli AL; Kaelin-Lang A; Conforto AB J Neurol Sci; 2017 Apr; 375():35-42. PubMed ID: 28320166 [TBL] [Abstract][Full Text] [Related]
2. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity. Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846 [TBL] [Abstract][Full Text] [Related]
3. Direct comparison of cortical excitability to transcranial magnetic stimulation in obstructive sleep apnea syndrome and restless legs syndrome. Lanza G; Lanuzza B; Aricò D; Cantone M; Cosentino FI; Pennisi M; Bella R; Pennisi G; Ferri R Sleep Med; 2015 Jan; 16(1):138-42. PubMed ID: 25534710 [TBL] [Abstract][Full Text] [Related]
4. Transcranial magnetic stimulation for evaluation of motor cortical excitability in restless legs syndrome/Willis-Ekbom disease. Magalhães SC; Kaelin-Lang A; Sterr A; do Prado GF; Eckeli AL; Conforto AB Sleep Med; 2015 Oct; 16(10):1265-73. PubMed ID: 26429756 [TBL] [Abstract][Full Text] [Related]
5. Influence of cabergoline on motor excitability in patients with restless legs syndrome. Gorsler A; Liepert J J Clin Neurophysiol; 2007 Dec; 24(6):456-60. PubMed ID: 18090527 [TBL] [Abstract][Full Text] [Related]
6. F-Wave Duration as a Specific and Sensitive Tool for the Diagnosis of Restless Legs Syndrome/Willis-Ekbom Disease. Congiu P; Fantini ML; Milioli G; Tacconi P; Figorilli M; Gioi G; Pereira B; Marrosu F; Parrino L; Puligheddu M J Clin Sleep Med; 2017 Mar; 13(3):369-375. PubMed ID: 28095964 [TBL] [Abstract][Full Text] [Related]
7. Willis-Ekbom Disease or Restless Legs Syndrome? Carlos K; Prado LB; Carvalho LB; Prado GF Sleep Med; 2015 Sep; 16(9):1156-9. PubMed ID: 26298794 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome. Kutukcu Y; Dogruer E; Yetkin S; Ozgen F; Vural O; Aydin H Muscle Nerve; 2006 Jan; 33(1):133-7. PubMed ID: 16175624 [TBL] [Abstract][Full Text] [Related]
10. Cortical excitability in drug naive juvenile myoclonic epilepsy. Puri V; Sajan PM; Chowdhury V; Chaudhry N Seizure; 2013 Oct; 22(8):662-9. PubMed ID: 23746624 [TBL] [Abstract][Full Text] [Related]
11. Quantitative sensory test for primary restless legs syndrome/Willis-Ekbom disease using the current perception threshold test. Cho YW; Kang MS; Kim KT; Do SY; Lim JG; Lee SY; Motamedi GK Sleep Med; 2017 Feb; 30():19-23. PubMed ID: 28215248 [TBL] [Abstract][Full Text] [Related]
12. Case series investigating the cortical silent period after burns using transcranial magnetic stimulation. Garside T; Wood FM; Vallence AM Burns; 2018 Aug; 44(5):1195-1202. PubMed ID: 29784557 [TBL] [Abstract][Full Text] [Related]
13. Default mode network disturbances in restless legs syndrome/Willis-Ekbom disease. Ku J; Lee YS; Chang H; Earley CJ; Allen RP; Cho YW Sleep Med; 2016 Jul; 23():6-11. PubMed ID: 27692278 [TBL] [Abstract][Full Text] [Related]
14. Sensorimotor white matter projections and disease severity in primary Restless Legs Syndrome/Willis-Ekbom disease: a multimodal DTI analysis. de Paiva JPQ; Magalhães SC; Moura LM; Sato JR; Amaro E; Sterr A; Schlaffke L; Eckeli AL; do Prado GF; Conforto AB Sleep Med; 2020 Sep; 73():106-116. PubMed ID: 32805477 [TBL] [Abstract][Full Text] [Related]
15. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome. Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629 [TBL] [Abstract][Full Text] [Related]
16. Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study. Rinaldi F; Galbiati A; Marelli S; Cusmai M; Gasperi A; Oldani A; Zucconi M; Padovani A; Ferini Strambi L J Neurol; 2016 Feb; 263(2):396-402. PubMed ID: 26725086 [TBL] [Abstract][Full Text] [Related]
17. Living with Restless Legs Syndrome/Willis-Ekbom Disease. Tachibana N Sleep Med Clin; 2015 Sep; 10(3):359-67, xv. PubMed ID: 26329446 [TBL] [Abstract][Full Text] [Related]
18. Which Factors in Spinocerebellar Ataxia Type 3 Patients Are Associated with Restless Legs Syndrome/Willis-Ekbom Disease? Gitaí LLG; Éckeli AL; Sobreira-Neto MA; Diniz PRB; Santos AC; Júnior WM; Fernandes RMF Cerebellum; 2021 Feb; 20(1):21-30. PubMed ID: 32946033 [TBL] [Abstract][Full Text] [Related]
19. Automated-parameterization of the motor evoked potential and cortical silent period induced by transcranial magnetic stimulation. Rábago CA; Lancaster JL; Narayana S; Zhang W; Fox PT Clin Neurophysiol; 2009 Aug; 120(8):1577-87. PubMed ID: 19559646 [TBL] [Abstract][Full Text] [Related]
20. Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease). Todd G; Haberfield M; Faulkner PL; Hayes M; Wilcox RA; Rae C; Bulathsinhala T; Grunstein RR; Yee BJ; Double KL Clin Neurophysiol; 2015 Apr; 126(4):736-42. PubMed ID: 25113274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]